Researchers from the Columbia University Department of Neurology discovered a genetic variant that may reduce the odds of developing Alzheimer’s disease by up to 70%.
James Noble, MD, MS, Associate Professor of Neurology in the Taub Institute and the Sergievsky Center at CUMC discusses his diverse body of work and the motivation behind his passion projects.
Lawrence S. Honig, MD, PhD, Professor of Neurology at CUMC, comments on the suggestion that some people may have developed Alzheimer's disease after receiving growth hormones
Various programs around the country connect neurologic patients and caregivers with the arts. One such example is Arts & Minds, an organization founded by Dr. James M. Noble
Vagelos College of Physicians and Surgeons and College of Dental Medicine scientists awarded $3.97 million to study link between Alzheimer’s and periodontitis
Dr. Manly was elected to NAM for her pioneering work improving detection of cognitive impairment among racially, culturally, and socio-economically diverse adults
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.